Skip to main content
. 2019 Jan 21;7:16. doi: 10.1186/s40425-018-0464-1

Fig. 5.

Fig. 5

T-PNU anti-tumor protection is CD8 T cell-dependent. a, Tumor growth curves of EMT6-hHER2 tumor-bearing animals upon treatment with T-PNU (1 mg/kg, 2x), α-CD8 (10 mg/kg), or α-CD8 followed by T-PNU treatment, P-value < 0.0001 *** (Gehan-Breslow-Wilcoxon Test). b, Overall survival curves of a